Englewood, CO—Swedish Medical Center, a Level 1 trauma center and The Joint Commission–accredited Stroke, Cardiology, and Cancer Center that cares for more than 200,000 patients annually with a team of 2000 dedicated employees, 500 volunteers, and more than 1300 physicians, is the first Colorado hospital to earn The Joint Commission’s Gold Seal of Approval for certification in pancreatic and lung cancer care. As the third medical center in the country to be accredited for pancreatic cancer care and the fifth in the country to be accredited for lung cancer care, this certification recognizes dedication to continuous compliance with The Joint Commission’s national standards for quality healthcare.
“This achievement acknowledges the exemplary care we provide to the patients of Colorado and the surrounding region,” said Mary M. White, president and CEO of the Swedish Medical Center. “Our oncology team deserves to be recognized for their outstanding dedication to quality care.”
In February, Swedish underwent a rigorous on-site survey by The Joint Commission that evaluated compliance with standards of care specific to the needs of patients, including infection prevention and control, leadership, and medication management. The Joint Commission is a prestigious national medical accreditation organization that accredits more than 20,000 healthcare organizations and programs in the United States.
Swedish’s pancreatic cancer services are offered as a part of the Center for Diseases of the Liver and Pancreas. As a leader in services offered in Colorado, the center has dedicated physicians and staff committed to comprehensive care and treatment to all patients with pancreatic cancer. They provide the most advanced treatments and compassionate care to ensure that all of their patients achieve the best possible outcome.
The lung cancer care program’s diverse team of specialists, advanced resources, and full continuum of lung cancer care are important qualities that have helped Swedish earn the trust and confidence of its patients and referring physicians. Patients are able to work directly with staff to coordinate and manage their treatments, allowing them to devote more time and energy to achieve restoration in their health.
Both pancreatic and lung cancer patients benefit from having personal one-on-one care from the entire staff. Patients have full access to nurse navigators, multidisciplinary care conferences, state-of-the-art equipment, and expert clinical care.—Source: PRNewswire, June 6, 2013